Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
First person profile: Supriya G. Mohile, MD, MS: A respected geriatric oncologist, Dr. Mohile has conducted innovative research on improving care for older patients with cancer
Summary
Ms. Canin and Dr. Mohile collaborated to involve patients and caregivers in geriatric oncology studies, forming the SCOREboard advisory group. Dr. Mohile received a $2 million grant to create infrastructure for cancer and aging studies, and she is recognized as a leader in geriatric oncology. Her research integrates geriatrics into oncology, addressing the growing older cancer patient population, with a focus on community oncology practices. Geriatric assessments (GAs) are used to improve outcomes for older cancer patients, identifying those at high risk for chemotherapy toxicity. Dr. Mohile, Dr. Dale, and Dr. Hurria developed ASCO guidelines recommending GAs for chemotherapy decision-making in older patients. Dr. Mohile balances her professional life with personal interests, including dining, Zumba, and reading romance novels.
Beverly Canin, an 85-year-old breast cancer survivor and patient advocate, remembers when she first met Supriya G. Mohile, MD, MS, a geriatric oncologist and the Philip and Marilyn Wehrheim Professor in the division of hematology/oncology at the University of Rochester Medical Center (URMC) in New York. In 2011, Ms. Canin, who had begun attending annual meetings of the American Society of Clinical Oncology (ASCO), went to a session that focused on cancer in the “oldest old” adults, namely those aged ≥85 years. Dr. Mohile was part of that panel, along with her colleagues, William Dale, MD, PhD, who is currently the chair of supportive care medicine at the City of Hope cancer center in Duarte, California, and the late Arti Hurria, MD, who had served as director of the City of Hope's Center for Cancer and Aging...
Supriya G. Mohile, geriatric oncologist
Related Topics
You May Also Like
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis